Nanexa AB is a Sweden-based company engaged in the drug delivery systems industry. The Company specializes in the nanotechnology and research and development in life science. Its products portfolio is comprised of PharmaShell, a drug delivery system that allows for targeting and dosing of drugs; antifungal coating, a system that protects medical products from the in-growth of fungi; and low-friction coating for peripheral venous catheters.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

11-05 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26-10-28	SEK 10.18	-0.97%	280,670
26-10-27	SEK 10.28	-2.28%	389,595
26-10-26	SEK 10.52	-1.31%	696,071
26-10-23	SEK 10.66	+0.38%	598,870
26-10-22	SEK 10.62	-5.18%	641,980

Delayed Quote Nasdaq Stockholm

More quotes

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Nanexa AB

Company calendar

Market Closed - Nasdaq Stockholm 13:00:00 2026-10-28 EDT			5-day change	1st Jan Change
10.18 ^SEK	-0.97%		-9.11%	+128.76%

09-25	Healthcare Stocks Tick Higher as U.S. Stocks Recover Some Ground -- Healthcare Roundup	DJ
09-25	Stockholm market breaks gloomy trend with Friday gain	FW

Market Cap	1.94B 196M 176M 163M 147M 275M 18.68B 279M 775M 9.77B 736M 720M 31.02B	P/E 2024	-11.8x	P/E 2025	-60.9x
Enterprise Value	1.9B 192M 172M 159M 144M 269M 18.27B 272M 758M 9.56B 720M 705M 30.35B	EV / Sales 2024	11.8x	EV / Sales 2025	18.4x
Free-Float	72.76%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Nasdaq Stockholm	NANEXA	Delayed
CBOE		Real-time
Deutsche Boerse AG	40M	Delayed
CBOE		Real-time

09-25	Healthcare Stocks Tick Higher as U.S. Stocks Recover Some Ground -- Healthcare Roundup	DJ
09-25	Stockholm market breaks gloomy trend with Friday gain	FW
09-25	Nanexa CEO: Novo could have reason to acquire the company down the road - Di	FW
09-25	Stockholm Market Extends Gains at Midday	FW
09-25	European Midday Briefing : Shares Rise, Oil Drops on Renewed Uncertainty in the Middle East	DJ
09-25	Novo's EUR1.17 Billion Licensing Deal Sends Nanexa Stock Soaring	MT
09-25	Novo Nordisk to Pay Up to $1.3 Billion for Nanexa's Drug Delivery Technology	DJ
09-25	Nanexa shares soar on EUR1.17 billion Novo Nordisk deal for injection technology	RE
09-25	Novo Nordisk Licenses Nanexa Drug Delivery Technology	MT
09-25	Nanexa signs billion-euro deal with Novo Nordisk	FW
09-24	Novo Gains Exclusive Global License to Nanexa's PharmaShell Platform via EUR1.17 Billion Deal	MT
09-24	Nanexa and Novo Enter into EUR 1.165 Billion Global License and Collaboration Agreement for Long-Acting Injectables	CI
09-22	Forge Nano, Inc. and Nanexa AB Enter Joint Development Agreement to Advance Manufacturing for Ald-Coated Pharmashell® Long-Acting Injectable Medicines	CI

Nanexa AB Stock

Stocks

NANEXA

SE0007074166

Medical Equipment, Supplies & Distribution

Valuation: Nanexa AB

Chart: Nanexa AB

Latest news: Nanexa AB

Press Releases: Nanexa AB

News in other languages: Nanexa AB

Quotes and Performance

Price Extremes

Managers and Directors: Nanexa AB

Latest insider transactions

Drug Delivery Systems

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

09-26	Novo Nordisk signs multibillion licence deal for long-acting obesity and diabetes injections	AQ
09-24	Nanexa and Novo enter into EUR 1.165 billion global license and collaboration agreement for long-acting injectables	AQ
09-22	Forge Nano and Nanexa Enter Joint Development Agreement to Advance Manufacturing for ALD-Coated PharmaShell® Long-Acting Injectable Medicines	AQ
08-27	Nanexa publishes interim report for April - June 2026	AQ
06-18	Summer letter from Nanexa	AQ

09-29	Novo Nordisk schließt Lizenzabkommen über Adipositas-Wirkstoff mit Hengrui Pharma
09-25	Novo Nordisk zahlt bis zu 1,2 Mrd Euro für Nanexa-Technologie

1 day	-0.97%
1 week	-9.11%
Current month	-3.42%
1 month	-7.29%
3 months	+155.46%
6 months	+170.74%
Current year	+128.76%

1 week	10.18	10.86
1 month	9.2	11.7
Current year	3.22	15.5
1 year	1.4	15.5
3 years	0.6	15.5
5 years	0.6	15.5
10 years	0.6	15.5

Manager	Title	Age	Since
Mårten Rooth CTO	Chief Tech/Sci/R&D Officer	49	-
Anders Johansson PRN	Corporate Officer/Principal	50	2008-12-31
David Westberg CEO	Chief Executive Officer	66	2015-03-31

Director	Title	Age	Since
Göran Albert Ando CHM	Chairman	77	2020-06-01
Eva Nilsagård BRD	Director/Board Member	62	2021-04-30
Birgit Stattin Norinder BRD	Director/Board Member	78	2021-05-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NANEXA AB	-0.97%	-9.11%	+423.12%	+920.04%	198M
ABBOTT LABORATORIES	-0.45%	+2.12%	-18.93%	+10.54%	178B
STRYKER CORPORATION	+0.86%	+2.15%	-19.13%	+16.07%	116B
MEDTRONIC PLC	+0.88%	+1.88%	+1.66%	+36.51%	115B
ESSILORLUXOTTICA	-2.26%	+2.24%	-44.03%	+5.76%	93.1B
CENCORA, INC.	-0.31%	-4.72%	-3.36%	+72.86%	62.09B
HOYA CORPORATION	+0.19%	+0.32%	+10.94%	+84.75%	55.87B
BECTON, DICKINSON AND COMPANY	+0.07%	+0.42%	+5.94%	-22.43%	53.12B
IDEXX LABORATORIES, INC.	+0.30%	+1.70%	-11.26%	+43.83%	44.22B
ALCON INC.	+0.10%	+3.08%	-3.06%	-8.71%	33.59B
Average	-0.16%	+0.50%	+34.19%	+115.92%	75.12B
Weighted average by Cap.	-0.10%	+1.39%	-12.38%	+24.45%

	2024	2025
Net sales	24.36M 2.46M 2.2M 2.04M 1.85M 3.45M 234M 3.49M 9.7M 122M 9.22M 9.02M 389M	36.15M 3.64M 3.27M 3.02M 2.74M 5.12M 347M 5.18M 14.4M 182M 13.68M 13.39M 577M
Net income	-24.9M -2.51M -2.25M -2.08M -1.89M -3.52M -239M -3.57M -9.92M -125M -9.42M -9.22M -397M	-11.39M -1.15M -1.03M -952K -863K -1.61M -109M -1.63M -4.54M -57.23M -4.31M -4.22M -182M
Net Debt	-6.59M -664K -596K -551K -499K -932K -63.26M -943K -2.62M -33.1M -2.49M -2.44M -105M	-42.37M -4.27M -3.83M -3.54M -3.21M -6M -407M -6.07M -16.88M -213M -16.03M -15.69M -676M